Joshua B Cohen insider trades

Open-market stock purchases and sales by Joshua B Cohen, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 6, 2022.

Recent trades

DateStockTradeValue
Sep 10, 2026AMLX Amylyx Pharmaceuticals, IncSold$950K
Sep 10, 2026AMLX Amylyx Pharmaceuticals, IncSold$30.5K
Aug 18, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AMLX Amylyx Pharmaceuticals, IncSold$424K
Feb 2, 2026AMLX Amylyx Pharmaceuticals, IncSold$228K
Jan 16, 2026AMLX Amylyx Pharmaceuticals, IncSold$27.3K
Jan 16, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Jan 15, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Jan 15, 2026AMLX Amylyx Pharmaceuticals, IncSold$1.9M
Jan 6, 2026AMLX Amylyx Pharmaceuticals, IncSold$85.6K

Companies traded

  • AMLX Amylyx Pharmaceuticals, Inc: 20 sales, last Sep 10, 2026

Get free alerts when Joshua B Cohen files a new trade →